|
MAGED4B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.624700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.639800E-02 |
| Normal-vs-Stage2 |
9.803600E-02 |
| Normal-vs-Stage3 |
1.561010E-03 |
| Normal-vs-Stage4 |
2.804800E-01 |
| Stage1-vs-Stage2 |
4.393800E-01 |
| Stage1-vs-Stage3 |
1.917860E-02 |
| Stage1-vs-Stage4 |
5.501600E-01 |
| Stage2-vs-Stage3 |
2.057200E-01 |
| Stage2-vs-Stage4 |
8.082200E-01 |
| Stage3-vs-Stage4 |
5.004600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.12450000000231E-05 |
| Normal-vs-AfricanAmerican |
1.187040E-01 |
| Normal-vs-Asian |
1.693620E-01 |
| Caucasian-vs-AfricanAmerican |
2.321700E-02 |
| Caucasian-vs-Asian |
7.204400E-01 |
| AfricanAmerican-vs-Asian |
7.170000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.073670E-02 |
| Normal-vs-Female |
3.64320000000307E-05 |
| Male-vs-Female |
5.395300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.267900E-02 |
| Normal-vs-Extreme_Weight |
7.769600E-02 |
| Normal-vs-Obese |
2.939900E-03 |
| Normal-vs-Extreme_Obese |
3.064200E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.603600E-01 |
| Normal_Weight-vs-Obese |
3.656200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.581760E-03 |
| Extreme_Weight-vs-Obese |
1.258760E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.476200E-03 |
| Obese-vs-Extreme_Obese |
1.975340E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.006020E-02 |
| Normal-vs-Age(41-60Yrs) |
1.203830E-03 |
| Normal-vs-Age(61-80Yrs) |
6.898600E-03 |
| Normal-vs-Age(81-100Yrs) |
5.660000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.237600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.814500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.075200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.564400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.276360E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.260300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.319660E-02 |
| Normal-VS-Type2 PRCC |
8.688400E-02 |
| Normal-VS-KIRP CIMP |
1.310200E-02 |
| Normal-VS-Unclassified PRCC |
2.817500E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.787600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.890300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.566200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.369700E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.548000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.110500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.554570E-01 |
| Normal-vs-N1 |
2.660000E-03 |
| Normal-vs-N2 |
1.135040E-01 |
| N0-vs-N1 |
1.062100E-02 |
| N0-vs-N2 |
1.406600E-01 |
| N1-vs-N2 |
4.268400E-01 |
|
|
